Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bioxytran's operating cash flow for the twelve months ending Jun 30, 2026 was -$874.32K. For fiscal 2025 it was -$526.46K. The highest annual figure on record is $9.27K in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$526.46K | – |
| FY2024 | Dec 31, 2024 | -$381.32K | – |
| FY2023 | Dec 31, 2023 | -$775.38K | – |
| FY2022 | Dec 31, 2022 | -$1.80M | – |
| FY2021 | Dec 31, 2021 | -$1.70M | – |
| FY2020 | Dec 31, 2020 | -$1.10M | – |
| FY2019 | Dec 31, 2019 | -$431.03K | – |
| FY2018 | Dec 31, 2018 | -$185.90K | – |
| FY2017 | Dec 31, 2017 | -$18.52K | – |
| FY2016 | Dec 31, 2016 | -$42.39K | – |
| FY2015 | Dec 31, 2015 | -$2.69K | – |
| FY2014 | Dec 31, 2014 | -$16.32K | -276.0% |
| FY2013 | Dec 31, 2013 | $9.27K | – |
| FY2012 | Dec 31, 2012 | -$63.68K | – |
| FY2011 | Dec 31, 2011 | -$398.76K | – |
| FY2010 | Dec 31, 2010 | -$75.80K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$349.77K | – |
| Q1 FY2026 | Mar 31, 2026 | -$238.61K | – |
| Q4 FY2025 | Dec 31, 2025 | -$236.97K | – |
| Q3 FY2025 | Sep 30, 2025 | -$48.97K | – |
| Q2 FY2025 | Jun 30, 2025 | -$73.20K | – |
| Q1 FY2025 | Mar 31, 2025 | -$167.32K | – |
| Q4 FY2024 | Dec 31, 2024 | -$127.94K | – |
| Q3 FY2024 | Sep 30, 2024 | -$73.55K | – |
| Q2 FY2024 | Jun 30, 2024 | -$70.27K | – |
| Q1 FY2024 | Mar 31, 2024 | -$109.57K | – |
| Q4 FY2023 | Dec 31, 2023 | -$92.63K | – |
| Q3 FY2023 | Sep 30, 2023 | -$342.58K | – |
| Q2 FY2023 | Jun 30, 2023 | -$153.28K | – |
| Q1 FY2023 | Mar 31, 2023 | -$186.89K | – |
| Q4 FY2022 | Dec 31, 2022 | -$154.69K | – |
| Q3 FY2022 | Sep 30, 2022 | -$718.77K | – |
| Q2 FY2022 | Jun 30, 2022 | -$238.79K | – |
| Q1 FY2022 | Mar 31, 2022 | -$691.41K | – |
| Q4 FY2021 | Dec 31, 2021 | -$143.66K | – |
| Q3 FY2021 | Sep 30, 2021 | -$144.05K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$391.10K | – |
| Q4 FY2020 | Dec 31, 2020 | -$890.83K | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.73K | – |
| Q2 FY2020 | Jun 30, 2020 | -$39.65K | – |
| Q1 FY2020 | Mar 31, 2020 | -$156.79K | – |
| Q4 FY2019 | Dec 31, 2019 | -$185.60K | – |
| Q3 FY2019 | Sep 30, 2019 | -$32.05K | -1246.4% |
| Q2 FY2019 | Jun 30, 2019 | -$73.65K | -1473140.0% |
| Q1 FY2019 | Mar 31, 2019 | -$139.73K | – |
| Q4 FY2018 | Dec 31, 2018 | -$188.63K | -171577.3% |
| Q3 FY2018 | Sep 30, 2018 | $2.80K | -88.3% |
| Q2 FY2018 | Jun 30, 2018 | $5 | – |
| Q1 FY2018 | Mar 31, 2018 | -$80 | – |
| Q4 FY2017 | Dec 31, 2017 | $110 | – |
| Q3 FY2017 | Sep 30, 2017 | $23.80K | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.40K | – |
| Q1 FY2017 | Mar 31, 2017 | -$8.04K | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.68K | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.94K | – |
See a number that looks wrong?